Record Rs 1,950 Cr Respiratory Drug Sales in Dec 2025
Sales of anti-asthma and respiratory medicines surged to a record Rs 1,950 crore in Dec 2025, highlighting the severe health cost of India's toxic air. Experts warn of a consistent rise in pollution-linked illnesses. Read more.